Prognostic factors for treatment of malignant lymphoma in dogs

Journal of the American Veterinary Medical Association

Volumn 205, Issue 12, 1994, Pages 1722-1728

  Teske, E ^a   Van Heerde, P ^a   Rutteman, G R ^a   Kurzman, I D ^a   Moore, P F ^a   MacEwen, E G ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; VINCRISTINE;

ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; DOG; HISTOLOGY; LYMPHOMA; NONHUMAN; PHENOTYPE; T LYMPHOCYTE; VETERINARY MEDICINE;

ANIMAL; ANTINEOPLASTIC AGENTS; ASPARAGINASE; DOG DISEASES; DOGS; ENZYMES, IMMOBILIZED; FEMALE; IMMUNOPHENOTYPING; LYMPHOMA; MALE; POLYETHYLENE GLYCOLS; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0028576367     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)